Drug Type Small molecule drug |
Synonyms Quinupristin/Dalfopristin, RP 57669/RP54476, RP 59500 + [4] |
Target |
Action inhibitors |
Mechanism 50S subunit inhibitors(50S ribosomal subunit inhibitors) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United Kingdom (01 Jul 1999), |
Regulation- |
Molecular FormulaC87H117N13O19S2 |
InChIKeyPPKJUHVNTMYXOD-PZGPJMECSA-N |
CAS Registry126602-89-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Dalfopristin/Quinupristin | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bacteremia | United States | 21 Sep 1999 | |
Complicated skin and skin structure infection | United States | 21 Sep 1999 | |
Vancomycin-resistant enterococcal infection | United States | 21 Sep 1999 | |
Gram-Positive Bacterial Infections | United Kingdom | 01 Jul 1999 |